What is Vitro3D?
Vitro3D operates at the intersection of advanced materials science and information technology, specializing in high-speed volumetric 3D printing. Unlike traditional layer-by-layer manufacturing, which is often constrained by time and geometric complexity, Vitro3D utilizes a novel cartridge-based approach to print intricate objects in mere seconds. This technological breakthrough is particularly transformative for the production of dental aligners and the creation of complex scaffolds for 3D cell culture and tissue engineering. By addressing the bottlenecks of current photopolymerization methods, the company is carving out a unique market position as a critical enabler for high-throughput, precision-engineered medical and industrial components.
How much funding has Vitro3D raised?
Vitro3D has raised a total of $2.4M across 2 funding rounds:
Angel/Seed
$1.3M
Debt
$1.1M
Angel/Seed (2022): $1.3M with participation from Caruso Ventures and Venture Center
Debt (2026): $1.1M, investors not publicly disclosed
Key Investors in Vitro3D
Caruso Ventures
Caruso Ventures is an investment firm that focuses on tech-enabled companies led by effective CEOs, primarily in Colorado. They typically invest between $500k to $2.5 million at the early revenue ramp stage and are open to leading or following in investments across various industries.
Venture Center
Venture Center is India's largest technology incubator, hosted by CSIR's National Chemical Laboratory, that has supported over 750 science-based startups since its inception in 2006. The incubator provides a comprehensive innovation ecosystem, offering services such as mentoring, funding, scientific assistance, and specialized resource centers.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Vitro3D?
With the recent influx of capital, Vitro3D is expected to prioritize the scaling of its manufacturing infrastructure and the expansion of its R&D capabilities. The strategic roadmap likely includes deepening its penetration into the dental aligner market, where speed and precision are primary competitive advantages. Furthermore, the company is anticipated to leverage its recent financing to forge deeper partnerships within the life sciences industry, specifically targeting the growing demand for scalable tissue engineering solutions. As the firm matures, the focus will shift toward optimizing its supply chain and establishing a broader commercial footprint, ensuring that its volumetric printing technology becomes a standard tool for high-complexity manufacturing environments.
See full Vitro3D company page
